Movement Disorders · 2021 · 17 citations · 15 references
MedicineClinical SciencesNeurologyClinical BiochemistryMolecular PathologyNeuropathologyGlial PathologyWilson DiseaseConcentrationHepatic ManifestationsNeuroinflammatory BiomarkersNeuroinflammatory MarkersNeurological Disease BiomarkersNeurological Disease CasesWilson Disease Differential DiagnosisWilson Disease Pathophysiology
BACKGROUND: Wilson disease is a rare, disabling, neurological genetic disease. Biomarkers of brain damage are less well developed. OBJECTIVE: The aim of this study was to evaluate the utility of plasma glial fibrillary acidic protein as a biomarker for neurological involvement in patients with Wilson disease. METHODS: This prospective cross-observational study compared plasma glial fibrillary acidic protein concentration among different subtypes of patients with Wilson disease and healthy control subjects. Plasma glial fibrillary acidic protein levels were measured in 94 patients and 25 healthy control subjects. Patients were divided into two subtypes: patients with neurological manifestations (n = 74) or hepatic manifestations (n = 20). RESULTS: Median levels of plasma glial fibrillary acidic protein were significantly elevated in patients with neurological manifestations (143.87 pg/mL) compared with those with hepatic manifestations (107.50 pg/mL) and healthy control subjects (86.85 pg/mL). Receiver operating characteristic curve revealed that a plasma glial fibrillary acidic protein cutoff value of 128.8 pg/mL provides sufficient sensitivity (80.0%) and specificity (63.5%) to differentiate patients with neurological manifestations from those with hepatic manifestations. CONCLUSIONS: Plasma glial fibrillary acidic protein may serve as a biomarker for distinguishing different subtypes of Wilson disease. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
15
Sue Richards, Nazneen Aziz, Sherri J. Bale et al. · Genetics in Medicine · 2015 · 32.2K citations · Full text
EASL Clinical Practice Guidelines: Wilson’s disease
Journal of Hepatology · 2012 · 1.2K citations
Handbook of Clinical Neurology
Robert P. Dinapoli · Neurology · 1972 · 581 citations
John K. Yue, Esther L. Yuh, Frederick K. Korley et al. · The Lancet Neurology · 2019 · 241 citations
Medicine, Neuroscience, Radiology +13